Status:
NOT_YET_RECRUITING
Mechanistic Underpinnings of Preeclampsia
Lead Sponsor:
University of Arizona
Conditions:
Preeclampsia
Eligibility:
FEMALE
18+ years
Brief Summary
Preeclampsia is a dreadful disease with significant morbidity and mortality. Despite decades of research, we still need a proper diagnostic test or therapeutic option to treat this disorder. The propo...
Eligibility Criteria
Inclusion
- Healthy Adults:
- • Healthy non-pregnant with previous normal pregnant women
- Non-Health Adults:
- • Patients will be admitted with the diagnosis of preeclampsia according to the internationally accepted definition of preeclampsia: Blood pressure measurement of 140/90 mm Hg or an increase of 30 mm Hg systolic or 15 mm Hg diastolic over baseline values on at least two occasions, six or more hours apart and proteinuria; 300 mg/24 hour after 20th week of gestation.
- Pregnant Women:
- Groups 3 - 6 will include pregnant women at different trimesters.
- Criteria common to all groups:
- The study will be conducted only in females aged 18 or above.
- Patients in all the groups will be matched for age, which will be 18 or above.
- Women will be matched for body mass index; criteria for normal body mass index will be used based on the Center for Disease Control and Prevention Guidelines.
- Patients with premature rupture of the membrane, non-preeclamptic preterm labor, IUGR, placental abruption, twin? Any other complications during the pregnancy will be excluded from the study.
- Patients with any evidence of genetic or non-genetic malformations of the fetus will be excluded from the study.
- The study will be conducted on women who are non-smokers and do not consume alcohol or recreational drugs.
- The study will be conducted only on primigravida females to minimize phenotyping variability.
- The women with a known history of any chronic disorder, including but not limited to hypertension, diabetes, pulmonary, renal, cardiac, or cerebrovascular disorders, will be excluded from the studies.
Exclusion
Key Trial Info
Start Date :
July 25 2026
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2029
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06567899
Start Date
July 25 2026
End Date
December 31 2029
Last Update
November 26 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.